NCT04498013 - Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52 | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

April 1, 2022

Study Completion Date

May 1, 2022

Conditions

Mammographic Breast Density

Interventions

DRUG

Cyclodynon

Cyclodynon 1 tablet a day during 6 menthes period.

BEHAVIORAL

Lifestyl modification

Measures to normalize the hygiene of work and rest. A diet aimed at achieving an optimal body mass index. Teaching relaxation techniques to increase resistance to chronic stress.

Trial Locations (1)

61057

RECRUITING

Clinical and diagnostics center, Kharkiv